<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1383333</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2024.1383333</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Causal association between major depressive disorder and venous thromboembolism: a bidirectional mendelian randomization study</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2024.1383333">10.3389/fgene.2024.1383333</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Hong-Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1734618/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Li-Hong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2746711/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Yong-Bo</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1723483/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Hai-Shan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacy</institution>, <institution>Qingdao University Medical College Affiliated Yantai Yuhuangding Hospital</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Ultrasound</institution>, <institution>Qingdao University Medical College Affiliated Yantai Yuhuangding Hospital</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Center for Evidence-Based and Translational Medicine</institution>, <institution>Zhongnan Hospital of Wuhan University</institution>, <addr-line>Wuhan</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Intensive Care Unit</institution>, <institution>Yantai Yeda Hospital</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/748261/overview">Ilya Blokhin</ext-link>, University of Miami, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/308221/overview">Zachary Freyberg</ext-link>, University of Pittsburgh, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2745206/overview">Loay Alrojolah</ext-link>, Yale University, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yong-Bo Wang, <email>wangyb20172030@163.com</email>; Hai-Shan Wang, <email>haishan003@163.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1383333</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>06</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Li, Wang, Wang, Wang and Wang.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Li, Wang, Wang, Wang and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Purpose</title>
<p>Major depressive disorder (MDD) and venous thromboembolism (VTE) may be linked in observational studies. However, the causal association remains ambiguous. Therefore, this study investigates the causal associations between them.</p>
</sec>
<sec>
<title>Methods</title>
<p>We performed a two-sample univariable and multivariable bidirectional Mendelian randomization (MR) analysis to evaluate the associations between MDD and VTE. The summary genetic associations of MDD statistics were obtained from the Psychiatric Genomics Consortium and UK Biobank. Information on VTE, deep vein thrombosis (DVT), and pulmonary embolism (PE) were obtained from the FinnGen Biobank. Inverse-variance weighting was used as the main analysis method. Other methods include weighted median, MR-Egger, Simple mode, and Weighted mode.</p>
</sec>
<sec>
<title>Results</title>
<p>Univariable MR analysis revealed no significant associations between MDD and VTE risk (odds ratio (OR): 0.936, 95% confidence interval (CI): 0.736&#x2013;1.190, <italic>p</italic> &#x3d; 0.590); however, after adjusting the potential relevant polymorphisms of body mass index and education, the multivariable MR analysis showed suggestive evidence of association between them (OR: 1.163, 95% CI: 1.004&#x2013;1.346, <italic>p</italic> &#x3d; 0.044). Univariable MR analysis also revealed significant associations between MDD and PE risk (OR: 1.310, 95% CI: 1.073&#x2013;1.598, <italic>p</italic> &#x3d; 0.008), but the association between them was no longer significant in MVMR analysis (<italic>p</italic> &#x3d; 0.072). We found no significant causal effects between MDD and DVT risk in univariable or multivariable MR analyses. There was also no clear evidence showing the causal effects between VTE, PE, or DVT and MDD risk.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>We provide suggestive genetic evidence to support the causal association between MDD and VTE risk. No causal associations were observed between VTE, PE, or DVT and MDD risk. Further validation of these associations and investigations of potential mechanisms are required.</p>
</sec>
</abstract>
<kwd-group>
<kwd>major depressive disorder</kwd>
<kwd>venous thromboembolism</kwd>
<kwd>risk factor</kwd>
<kwd>singlenucleotide polymorphisms</kwd>
<kwd>mendelian randomization</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Statistical Genetics and Methodology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a multifactorial disorder disease with hereditary and acquired risk factors (<xref ref-type="bibr" rid="B35">Rosendaal, 1999</xref>). VTE has a high annual incidence of 1&#x2013;2 persons per 1,000 individuals and is a major contributor to the global disease burden (<xref ref-type="bibr" rid="B40">Wendelboe and Raskob, 2016</xref>; <xref ref-type="bibr" rid="B25">Khan et al., 2021</xref>). Any cause that can lead to venous endothelial injury, stagnant venous blood flow, and a hypercoagulable state of the blood is a risk factor for VTE (<xref ref-type="bibr" rid="B32">Piazza, 2015</xref>). Regarding the risk factors for VTE, in addition to the identified risk factors such as trauma, surgery, obesity, and genetic susceptibility to thrombosis, more unidentified factors may be related to VTE etiology (<xref ref-type="bibr" rid="B31">Pastori et al., 2023</xref>). Identifying high-risk patients for early risk stratification of patients may result in more effective treatment strategies (<xref ref-type="bibr" rid="B5">Barco et al., 2016</xref>; <xref ref-type="bibr" rid="B4">Barco et al., 2020</xref>).</p>
<p>Major depressive disorder (MDD) is a psychological disorder that changes an individual&#x2019;s emotional state, leading to diminished experience of positive emotions, cognitive impairments, and poor concentration; it is a serious threat to the physical and mental health of individuals (<xref ref-type="bibr" rid="B10">Dehn and Beblo, 2019</xref>). Increasing evidence shows that depression and prothrombotic states are associated with dysfunction of the stress response system (<xref ref-type="bibr" rid="B14">Gold, 2015</xref>; <xref ref-type="bibr" rid="B21">Hunter et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Sandrini et al., 2020</xref>). Several common mechanistic pathways, such as increased platelet activation, procoagulant activity, endothelial dysfunction, and inflammatory processes, may trigger the development of depression and VTE (<xref ref-type="bibr" rid="B14">Gold, 2015</xref>). Despite the plausibility of behavioral and biological mechanisms, the existing findings are inconsistent. In a prospective study, the risk of venous thrombosis was 1.6 times higher in patients with depression than in those without depression (<xref ref-type="bibr" rid="B3">Austin et al., 2013</xref>). However, a large prospective study showed that VTE risk was not significantly increased in women who reported depression or anxiety (<xref ref-type="bibr" rid="B30">Parkin et al., 2017</xref>). Concurrently, there may be a reverse causality between depression and VTE; a previous study showed a 2.35-fold increased risk of depression in individuals with VTE compared with the general population [9]. To date, based on the inconsistent results derived from observational studies, the relationship between MDD and VTE remains unclear. Additionally, previous studies investigating the relationship between MDD and VTE were observational, and conventional observational studies have difficulty determining whether noted correlations are causal because of limitations, including potential confounders, reversal causality bias, and measurement error (<xref ref-type="bibr" rid="B37">Sekula et al., 2016</xref>). Therefore, further evidence is required to elucidate the causal relationship between depression and VTE and the pathways that are potentially involved.</p>
<p>Mendelian randomization (MR) is a statistical method based on genetic variation that uses genetic variation already present in nature as an instrumental variable (IV) to simulate randomly assigned experimental conditions to investigate the causal association between risk factors and disease development (<xref ref-type="bibr" rid="B37">Sekula et al., 2016</xref>; <xref ref-type="bibr" rid="B12">Emdin et al., 2017</xref>). The central idea is that genetic variation is randomly distributed among individuals and is independent of environmental and behavioral factors. By exploiting the association between these genetic variants and the exposure factor of interest, the causal effect of that exposure on a particular outcome can be inferred (<xref ref-type="bibr" rid="B28">Lawlor et al., 2008</xref>). Therefore, this study aimed to investigate the causal associations between MDD and VTE (including DVT and PE) using univariable and multivariable bidirectional two-sample MR analyses.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Study design</title>
<p>This bidirectional two-sample MR analysis was based on the summary of genetic associations for different genome-wide association studies (GWAS) using single-nucleotide polymorphisms (SNPs) as IVs to investigate the causal associations between MDD and VTE. To gain reliable results, the effective IVs must satisfy three key assumptions during the MR analysis process: 1) the IVs must be strongly associated with the exposure; 2) IVs should not be associated with any confounders influencing the exposure and outcome association; and 3) IVs should be associated with the outcomes only <italic>via</italic> the exposures (<xref ref-type="bibr" rid="B12">Emdin et al., 2017</xref>). First, a forward MR analysis was performed to examine the associations between MDD and VTE. Next, a reverse MR analysis was performed to examine the associations of genetically determined VTE with MDD. The study design of MR analysis is shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Overview and assumptions of the Mendelian randomization study design. Assumption 1: The instrumental variables should be closely related to the risk factor of interest; assumption 2: The instrumental variables should not be associated with potential confounders; and assumption 3: The instrumental variables should affect the risk of outcome only through risk factors and not through other alternative pathways. SNP, single-nucleotide polymorphisms; MDD, major depressive disorder; VTE, venous thromboembolism; PE, pulmonary embolism; DVT, deep venous thrombosis; IVW, inverse-variance weighting; UVMR, univariable Mendelian randomization; MVMR, multivariable Mendelian randomization.</p>
</caption>
<graphic xlink:href="fgene-15-1383333-g001.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>2.2 Genetic data source of MDD and VTE</title>
<p>For our analyses, data regarding MDD and VTE were obtained from publicly available large-scale GWAS databases. The summary genetic associations of MDD statistics were obtained from the Psychiatric Genomics Consortium and UK Biobank, extracted from 170,756 cases and 329,443 controls based on European samples (<xref ref-type="bibr" rid="B17">Howard et al., 2019</xref>). To investigate the genetic associations with VTE, we extracted GWAS datasets from the FinnGen Biobank (Release 8, <ext-link ext-link-type="uri" xlink:href="https://finngen.gitbook.io/documentation/v/r8/data-download">https://finngen.gitbook.io/documentation/v/r8/data-download</ext-link>). The latest version of the database was used for VTE (17,048 cases and 325,451 controls), PE (8,170 cases and 333,487 controls), and DVT (8,077 cases and 295,014 controls). Based on the International Classification of Diseases version 9, the definitions of VTE, DVT, and PE were developed. Detailed information on the GWAS in our study is presented in <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2-3">
<title>2.3 Selection of IVs</title>
<p>From GWAS summary data of MDD and VTE, only SNPs strongly associated with exposure (<italic>p</italic> &#x3c; 5 &#xd7; 10<sup>&#x2212;8</sup>) were extracted as genetic instruments. Linkage disequilibrium among SNPs defined by <italic>r</italic>
<sup>2</sup> &#x3e; 0.001 or clump distance &#x3c;10,000&#xa0;kb and those with higher <italic>p</italic> values were discarded, and the remaining SNPs were used as instruments. Next, the SNPs were then harmonized to ensure that the effect alleles were consistent in terms of both outcome and exposure data. Subsequently, we performed Steiger filtering to determine whether the directionality of a single SNP was correct and removed SNPs that were more strongly associated with outcome than with exposure (<xref ref-type="bibr" rid="B16">Hemani et al., 2017</xref>). The strength of IVs was examined using F-statistics; when the corresponding F statistic was &#x3e;10, the instrument&#x2019;s strength was deemed to be sufficient (<xref ref-type="bibr" rid="B8">Brion et al., 2013</xref>). We applied <italic>m</italic>R<italic>n</italic>d for power calculation (<ext-link ext-link-type="uri" xlink:href="https://shiny.cnsgenomics.com/mRnd/">https://shiny.cnsgenomics.com/mRnd/</ext-link>), assuming a 5% type I error rate and power &#x2265;80%. We used the PhenoScanner database to investigate the previously reported associations between instrument SNPs and potential confounding factors, and SNPs associated with potential confounders or outcome variables at genome-wide significance (<italic>p</italic> &#x3c; 5 &#xd7; 10<sup>&#x2212;8</sup>) were removed (<xref ref-type="bibr" rid="B24">Kamat et al., 2019</xref>). The PhenoScanner database search revealed associations of instruments with education and body mass index (BMI) traits. Observational studies have also demonstrated that education and BMI are associated with the incidence of MDD and VTE (<xref ref-type="bibr" rid="B44">Z&#xf6;ller et al., 2012</xref>; <xref ref-type="bibr" rid="B33">Rahmani et al., 2020</xref>; <xref ref-type="bibr" rid="B20">Huet et al., 2021</xref>; <xref ref-type="bibr" rid="B41">Wickersham et al., 2021</xref>; <xref ref-type="bibr" rid="B11">de Wit et al., 2022</xref>). Therefore, we chose SNPs associated with education and BMI from GWAS for multivariable MR analysis. Details of the GWAS of risk cofounders are presented in <xref ref-type="sec" rid="s12">Supplementary Table S2</xref>.</p>
</sec>
<sec id="s2-4">
<title>2.4 Statistical analyses</title>
<p>In our study, we tested the heterogeneity using Cochran&#x2019;s Q test, and Cochran&#x2019;s Q-derived <italic>p</italic> &#x3c; 0.05 indicated heterogeneity. We applied inverse-variance weighting (IVW) as the primary analysis method to evaluate the relationship between MDD and VTE (<xref ref-type="bibr" rid="B9">Burgess et al., 2013</xref>). Furthermore, to assess the robustness of the results, other sensitivity analyses, including the weighted median (<xref ref-type="bibr" rid="B7">Bowden et al., 2016</xref>), MR-Egger regression (<xref ref-type="bibr" rid="B6">Bowden et al., 2015</xref>), weighted mode (<xref ref-type="bibr" rid="B15">Hartwig et al., 2017</xref>), simple mode (<xref ref-type="bibr" rid="B42">Zhu et al., 2022</xref>), and MR&#x2013;pleiotropy residual sum and outlier (MR-PRESSO) (<xref ref-type="bibr" rid="B39">Verbanck et al., 2018</xref>) were conducted. The IVW method synthesizes the effect derived from each instrument by using the inverse variance as the weight and is applied on the assumption that all SNPs are valid instrumental variables and completely independent of each other (<xref ref-type="bibr" rid="B9">Burgess et al., 2013</xref>). The weighted median model can provide consistent estimates when &#x2265;50% of the weights come from valid IVs (<xref ref-type="bibr" rid="B7">Bowden et al., 2016</xref>). In contrast, the MR-Egger method allows each IV to exhibit pleiotropy, and if the instrument strength is not related to these pleiotropic effects, the method is consistent (<xref ref-type="bibr" rid="B6">Bowden et al., 2015</xref>). The MR-Egger regression can inspect the horizontal pleiotropy through its intercept, and a <italic>p</italic>-value of &#x3e;0.05 indicates no potential horizontal pleiotropy (<xref ref-type="bibr" rid="B6">Bowden et al., 2015</xref>). The MR-PRESSO method can detect the outliers and generate estimates after removing the outliers, which is designed to test the difference in the estimation before and after the outlier correction, with <italic>p</italic> &#x3c; 0.05 of the distortion tests indicating a significant difference (<xref ref-type="bibr" rid="B39">Verbanck et al., 2018</xref>). To identify whether the association could be affected by a particular single SNP, we used the leave-one-out test to test the sensitivity of the results. Finally, a multivariable MR analysis was performed to assess the causal relationship between MDD and VTE, adjusting for education and BMI in our models to assess the effect of potential confounders. The multivariable MR simultaneously considers multiple exposure factors; it limits the corresponding effects of SNP exposure on the characteristics of other assumed risk factors and eliminates possible biases (<xref ref-type="bibr" rid="B18">Huang G. et al., 2023</xref>).</p>
<p>All statistical analysis was performed using R Software (version 4.1.2). TwoSampleMR (0.5.7), MR-PRESSO (1.0), and Mendelian Randomization (0.7.0) packages were used for the MR analysis. After Bonferroni correction, results with <italic>p</italic> &#x3c; 0.05/3 (1 exposure &#xd7; 3 outcomes) &#x3d; 0.017 were considered statistically significant; estimates with a <italic>p</italic>-value between 0.017 and 0.05 were regarded as evidence suggesting an association in our study (<xref ref-type="bibr" rid="B19">Huang Y. et al., 2023</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Basic information of IVs</title>
<p>The F-statistic of all included SNPs was &#x3e;10, suggesting strong instruments (<xref ref-type="sec" rid="s12">Supplementary Tables S3, S4</xref>). The MR-Steiger showed that the SNPs were more strongly associated with exposure than with outcome. For the MR statistical power, assuming a 5% type I error rate and power &#x2265;80%, the power was low in both forward and reversed MR analysis (<xref ref-type="sec" rid="s12">Supplementary Table S5</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Univariable MR analysis of MDD and VTE risk</title>
<p>In the univariable MR analysis, independent SNPs (37 each) were selected and used as instruments in the MR analysis for the associations of MDD with VTE, PE, and DVT (<xref ref-type="sec" rid="s12">Supplementary Table S3</xref>). The IVW results showed no significant causal association between MDD and VTE (odds ratio (OR): 0.936, 95% confidence interval (CI): 0.736&#x2013;1.190, <italic>p</italic> &#x3d; 0.590) or DVT risk (OR: 0.936, 95% CI: 0.736&#x2013;1.190, <italic>p</italic> &#x3d; 0.590); furthermore, we observed similar results by using weighted median, MR Egger, weighted mode, and simple mode. The IVW results suggested a significant causal association between MDD and PE risk (OR: 1.310, 95% CI: 1.073&#x2013;1.598, <italic>p</italic> &#x3d; 0.008); however, we observed different results by using weighted median, MR Egger, weighted mode, and simple mode (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="sec" rid="s12">Supplementary Table S6</xref>). No significant association was observed between MDD and VTE, PE, or DVT risk using MR-PRESSO (<xref ref-type="sec" rid="s12">Supplementary Table S5</xref>). Cochran&#x2019;s Q test supported the existence of significant heterogeneity between exposure and outcome (<italic>P</italic>-heterogeneity &#x3c;0.05; <xref ref-type="sec" rid="s12">Supplementary Table S6</xref>). The MR-Egger intercept provided no statistical evidence of directional horizontal pleiotropy (all <italic>p</italic> &#x3e; 0.05, <xref ref-type="sec" rid="s12">Supplementary Figures S1&#x2013;S3</xref>). The leave-one-out analyses identified no individual IV, which largely affected the causal magnitude between MDD and the risk of VTE, PE, and DVT under the IVW model (<xref ref-type="sec" rid="s12">Supplementary Figures S4&#x2013;S6</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Associations of genetically predicted MDD with VTE development according to Mendelian randomization analyses. MDD, major depressive disorder; VTE, venous thromboembolism; PE, pulmonary embolism; DVT, deep venous thrombosis; OR, odds ratio; CI, confidence interval.</p>
</caption>
<graphic xlink:href="fgene-15-1383333-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Multivariable MR analysis of MDD and VTE risk</title>
<p>After adjusting for potentially relevant polymorphisms related to education and BMI, the multivariable MR results showed evidence suggestive of an association between MDD and VTE risk (OR: 1.163, 95% CI: 1.004&#x2013;1.346, <italic>p</italic> &#x3d; 0.044). The likely reason for this is that the true effect was masked by confounding factors since the univariable analyses were not adjusted for them. After the relevant adjustments were performed, the effect became evident.</p>
<p>No significant causal association was observed between MDD and the risk of PE (OR: 1.197, 95% CI: 0.984&#x2013;1.457, <italic>p</italic> &#x3d; 0.072). This difference may be because education and BMI are more strongly correlated with PE and are potential risk factors for PE. When these two variables were considered, their stronger explanatory power for PE caused that of MDD for PE to be relatively weaker, resulting in a non-significant correlation between MDD and PE. No genetic causal associations were observed between MDD and the risk of DVT in multivariable analyses (OR: 0.930, 95% CI: 0.755&#x2013;1.147, <italic>p</italic> &#x3d; 0.499) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Associations between MDD and VTE risk according to multivariable Mendelian randomization sensitivity analyses.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Exposure</th>
<th align="left">Outcome</th>
<th align="left">Methods</th>
<th align="left">OR</th>
<th align="left">95% CI</th>
<th align="left">
<italic>p</italic>-Value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">MDD</td>
<td align="left">VTE</td>
<td align="left">MVMR_IVW</td>
<td align="left">1.163</td>
<td align="left">(1.004&#x2013;1.346)</td>
<td align="left">0.044</td>
</tr>
<tr>
<td align="left">MDD</td>
<td align="left">PE</td>
<td align="left">MVMR_IVW</td>
<td align="left">1.197</td>
<td align="left">(0.984&#x2013;1.457)</td>
<td align="left">0.072</td>
</tr>
<tr>
<td align="left">MDD</td>
<td align="left">DVT</td>
<td align="left">MVMR_IVW</td>
<td align="left">0.930</td>
<td align="left">(0.755&#x2013;1.147)</td>
<td align="left">0.499</td>
</tr>
<tr>
<td align="left">VTE</td>
<td align="left">MDD</td>
<td align="left">MVMR_IVW</td>
<td align="left">1.008</td>
<td align="left">(0.984&#x2013;1.033)</td>
<td align="left">0.499</td>
</tr>
<tr>
<td align="left">PE</td>
<td align="left">MDD</td>
<td align="left">MVMR_IVW</td>
<td align="left">1.015</td>
<td align="left">(0.992&#x2013;1.039)</td>
<td align="left">0.193</td>
</tr>
<tr>
<td align="left">DVT</td>
<td align="left">MDD</td>
<td align="left">MVMR_IVW</td>
<td align="left">0.996</td>
<td align="left">(0.977&#x2013;1.014)</td>
<td align="left">0.640</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>MDD, major depressive disorder; VTE, venous thromboembolism; PE, pulmonary embolism; DVT, deep vein thrombosis; IVW, inverse-variance weighting; OR, odds ratio; CI, confidence interval; MVMR, multivariable Mendelian randomization.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-4">
<title>3.4 Univariable MR analysis of VTE and MDD risk</title>
<p>A total of 17, 10, and 11 independent SNPs were used to explore the causal associations of VTE, PE, and DVT with the MDD risk, respectively (<xref ref-type="sec" rid="s12">Supplementary Table S4</xref>). The IVW results suggested no significant associations between VTE (OR: 1.004, 95% CI: 0.989&#x2013;1.020, <italic>p</italic> &#x3d; 0.597), PE (OR: 1.019, 95% CI: 0.999&#x2013;1.039, <italic>p</italic> &#x3d; 0.066), or DVT (OR: 1.000, 95% CI: 0.984&#x2013;1.016, <italic>p</italic> &#x3d; 0.971) and MDD risk. We observed similar results by using weighted median, MR Egger, weighted mode, and simple mode (<xref ref-type="fig" rid="F3">Figure 3</xref> and <xref ref-type="sec" rid="s12">Supplementary Table S7</xref>). Additionally, no significant association was observed between VTE, PE, or DVT and MDD risk using MR-PRESSO (<xref ref-type="sec" rid="s12">Supplementary Table S5</xref>). Cochran&#x2019;s Q test supported the existence of significant heterogeneity between exposure and outcome (<italic>P</italic>-heterogeneity &#x3c;0.05; <xref ref-type="sec" rid="s12">Supplementary Table S7</xref>). The MR-Egger intercept provided no existence of horizontal pleiotropy (all <italic>p</italic> &#x3e; 0.05, <xref ref-type="sec" rid="s12">Supplementary Figures S7&#x2013;S9</xref>). The leave-one-out analyses showed that the MR analyses were stable and not affected by individual SNPs (<xref ref-type="sec" rid="s12">Supplementary Figures S10&#x2013;S12</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Associations of genetically predicted VTE with MDD according to Mendelian randomization analyses. MDD, major depressive disorder; VTE, venous thromboembolism; PE, pulmonary embolism; DVT, deep venous thrombosis; OR, odds ratio; CI, confidence interval.</p>
</caption>
<graphic xlink:href="fgene-15-1383333-g003.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Multivariable MR analysis of VTE and MDD risk</title>
<p>The multivariable MR analysis results were consistent with the univariable MR analysis results. No significant causal association was observed between VTE (OR: 1.008, 95% CI: 0.984&#x2013;1.033, <italic>p</italic> &#x3d; 0.499), PE (OR: 1.015, 95% CI: 0.992&#x2013;1.039, <italic>p</italic> &#x3d; 0.193), or DVT (OR: 1.014, 95% CI: 0.977&#x2013;1.014, <italic>p</italic> &#x3d; 0.640) and MDD risk (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>In this study, we performed a bidirectional two-sample MR analysis to investigate a genetically predicted causal association between MDD and VTE. Our findings provided suggestive evidence of the association between MDD and VTE risk. Furthermore, the reversed MR analysis found no genetic evidence of any causal association between VTE, PE, or DVT and MDD risk in either the univariable or the multivariable analyses.</p>
<p>We used BMI and education as confounders in our study. Previous studies have shown the correlation of BMI with depression and VTE. A representative psychiatric cohort study in the Netherlands showed that individuals with obesity at baseline had a significantly increased risk of developing any mood or anxiety disorder, even after adjusting for covariates compared to persons with a normal BMI (<xref ref-type="bibr" rid="B11">de Wit et al., 2022</xref>). Another observational study indicated that adiposity characteristics may help identify individuals at increased risk for neuropsychiatric comorbidity (<xref ref-type="bibr" rid="B20">Huet et al., 2021</xref>). A meta-analysis with 3,910,747 participants highlights obesity as a significant risk factor related to the incidence of VTE and PE (<xref ref-type="bibr" rid="B33">Rahmani et al., 2020</xref>). Additionally, the level of education was associated with depression and the incidence of VTE. A meta-analysis of 22 studies revealed that depression was associated with lower educational attainment (<xref ref-type="bibr" rid="B41">Wickersham et al., 2021</xref>). Furthermore, an epidemiological study from Sweden showed that individuals with high educational levels and those in several occupations requiring high levels of education had a lower risk of VTE, while those with low levels of education had an increased risk of VTE (<xref ref-type="bibr" rid="B44">Z&#xf6;ller et al., 2012</xref>).</p>
<sec id="s4-1">
<title>4.1 MDD and VTE risk</title>
<p>Overall, we verified the relationship between MDD and VTE, which is consistent with several experimental studies. Recently, studies have shown that depression may increase the risk of VTE through genetic and biological mechanisms as well as behavioural mechanisms (<xref ref-type="bibr" rid="B14">Gold, 2015</xref>; <xref ref-type="bibr" rid="B1">Adelborg et al., 2017</xref>). Amadio et al. (<xref ref-type="bibr" rid="B2">Amadio et al., 2017</xref>) investigated the relationship between depression and VTE at a molecular level and found that it may be related to the presence of SNP variants on the gene encoding brain-derived neurotrophic factor, which increases susceptibility to depression while leading to concomitant hypercoagulability and platelet hyperreactivity in individuals. Moreover, the levels of numerous pro-inflammatory markers are higher in patients with depression than in the general population (<xref ref-type="bibr" rid="B38">van Aken et al., 2002</xref>; <xref ref-type="bibr" rid="B34">Reitsma and Rosendaal, 2004</xref>). Pro-inflammatory markers may reduce the activity of vasodilatory factors through a microvascular endothelium-dependent mechanism, inhibit endothelial nitric oxide synthase activity, and increase endothelin-1 secretion, leading to abnormal microvessel constriction, vasodilatory dysfunction, narrowing of the lumen, slowing of the blood flow, and thrombosis (<xref ref-type="bibr" rid="B43">Zi-xin and Yong-gui, 2021</xref>). Furthermore, acquired behavioural habits in patients with depression are associated with VTE. An epidemiological survey in Europe (<xref ref-type="bibr" rid="B3">Austin et al., 2013</xref>) showed that 73% of patients with depression had hypodynamic symptoms, including reduced energy and fatigue, which further increased the risk of thrombosis.</p>
<p>Several previous observational studies have demonstrated the association between depression and VTE, while others have shown opposite results (<xref ref-type="bibr" rid="B3">Austin et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Lee et al., 2015</xref>; <xref ref-type="bibr" rid="B30">Parkin et al., 2017</xref>; <xref ref-type="bibr" rid="B27">Kunutsor et al., 2018</xref>; <xref ref-type="bibr" rid="B26">Kowal et al., 2020</xref>). A retrospective cohort study in Taiwan found that the risk of venous thrombosis was 1.38 times higher in patients with depression than in those without depression (<xref ref-type="bibr" rid="B29">Lee et al., 2015</xref>). In a prospective study, the risk of venous thrombosis was 1.6 times higher in patients with depression than in those without depression over a 12-year follow-up period (<xref ref-type="bibr" rid="B3">Austin et al., 2013</xref>). A systematic analysis of the risk of venous thrombosis in all psychiatric disorders collected since 1998 showed that the risk of venous thrombosis in patients with depression was 1.29 times higher than that in controls (<xref ref-type="bibr" rid="B26">Kowal et al., 2020</xref>). The systematic review and meta-analysis of observational studies published in 2018 included eight observational studies involving 960,113 non-overlapping participants and 9,027 VTE cases. Their results showed an increased risk of VTE in individuals with depression (RR &#x3d; 1.31) compared with those without depression (<xref ref-type="bibr" rid="B27">Kunutsor et al., 2018</xref>). However, some studies showed inconsistent results. For example, a large prospective study involving women in the United Kingdom demonstrated that VTE risk was not significantly increased in women who reported being treated for depression or anxiety but did not use antidepressants or other psychotropic drugs (hazard ratio, 1.19) (<xref ref-type="bibr" rid="B30">Parkin et al., 2017</xref>).</p>
<p>Nevertheless, the precise pathophysiology underlying the association between MDD and VTE remains unknown. Therefore, our MR analysis was conducted to clarify the connection between them, and the results provide novel insights into the impact of MDD on VTE and potential avenues for prevention.</p>
</sec>
<sec id="s4-2">
<title>4.2 VTE and MDD risk</title>
<p>In our study, we observed no association between VTE and MDD risk, which differed from the results of previous studies.</p>
<p>Previous studies have shown that VTE may lead to depression through various psychosocial mechanisms. VTE is an acute, life-threatening event that causes deterioration in functioning, including pain, swelling, and reduced mobility, resulting in a reduced quality of life; additionally, an increased risk of bleeding due to the prolonged use of anticoagulants may lead to depression (<xref ref-type="bibr" rid="B13">Ghanima et al., 2018</xref>; <xref ref-type="bibr" rid="B22">J&#xf8;rgensen et al., 2021</xref>). A 10-year population-cohort study involving more than 380,000 patients in Sweden showed that individuals diagnosed with VTE had a 2.35-fold increased risk of depression compared with the general population, and the risk estimates were moderately attenuated after adjusting for socioeconomic status and comorbidities (<xref ref-type="bibr" rid="B23">J&#xf8;rgensen et al., 2023</xref>). However, the observed associations may be due to confounding factors such as education level, lifestyle, diet, or mobility problems, which are common features in some of these patients. In our study, we eliminated the confounders and found no association between VTE and MDD risk. To the best of our knowledge, this is the first comprehensive MR examination of the risks associated with venous thrombosis and depression.</p>
</sec>
<sec id="s4-3">
<title>4.3 Strengths and limitations</title>
<p>Our study has several strengths. First, according to the core principles of MR, this method can largely avoid the influence of reverse causality and confounding factors, which typically affect the results of conventional observational studies. Second, in this study, two-sample bidirectional MR was first applied to investigate the causal relationship between MDD and VTE, considering the large sample size and the comprehensive types of VTE. Third, regarding instrument selection, we had a strict selection threshold (<italic>p</italic> &#x3c; 5 &#xd7; 10<sup>&#x2212;8</sup>) to reduce weak instrument bias. The F-statistics of all associations in our study exceeded 10, indicating the appropriate strength of the genetic instruments and the absence of weak instrument bias. Additionally, we used the multivariable MR methods to account for the potential pleiotropic associations between MDD and VTE.</p>
<p>However, our study has some limitations. First, to ensure homogeneity of genetic backgrounds, our study only included individuals of European descent, thereby limiting the generalizability of our results to other ethnic populations. Second, multivariable analysis could not overcome bias owing to pleiotropic effects from confounders other than education or BMI. Furthermore, because our findings may have had insufficient statistical power, a large amount of data from the GWAS databases is required to confirm the relationship between depression and different types of VTE.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>Our MR analysis provided suggestive genetic evidence to support the causal association between MDD and VTE risk. Moreover, no causal associations were observed between VTE, PE, or DVT and MDD risk. Further validation of these associations and investigations of potential mechanisms are required.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>.</p>
</sec>
<sec id="s7">
<title>Ethics statement</title>
<p>Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>H-YL: Conceptualization, Formal Analysis, Software, Writing&#x2013;original draft, Writing&#x2013;review and editing. L-HW: Conceptualization, Data curation, Formal Analysis, Methodology, Writing&#x2013;original draft. JW: Data curation, Methodology, Writing&#x2013;original draft. Y-BW: Methodology, Software, Supervision, Validation, Writing&#x2013;review and editing. H-SW: Conceptualization, Project administration, Supervision, Validation, Visualization, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>We gratefully acknowledge the following consortiums: the Psychiatric Genomics Consortium (PGC), the United Kingdom Biobank (UKB), and the FinnGen Consortium for making their GWAS summary-level statistics publicly available. We thank all investigators for sharing these data.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2024.1383333/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2024.1383333/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.DOCX" id="SM1" mimetype="application/DOCX" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adelborg</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sundb&#xf8;ll</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Videbech</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>E. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The risk of thromboembolism in users of antidepressants and antipsychotics</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>906</volume>, <fpage>351</fpage>&#x2013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1007/5584_2016_125</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amadio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>G. I.</given-names>
</name>
<name>
<surname>Tarantino</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gianellini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ieraci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brioschi</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>BDNFVal66met polymorphism: a potential bridge between depression and thrombosis</article-title>. <source>Eur. Heart J.</source> <volume>38</volume> (<issue>18</issue>), <fpage>1426</fpage>&#x2013;<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehv655</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Austin</surname>
<given-names>A. W.</given-names>
</name>
<name>
<surname>Wissmann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Von Kanel</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Stress and hemostasis: an update</article-title>. <source>Semin. Thromb. Hemost.</source> <volume>39</volume> (<issue>8</issue>), <fpage>902</fpage>&#x2013;<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1055/s-0033-1357487</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mahmoudpour</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Valerio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Klok</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>M&#xfc;nzel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Middeldorp</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database</article-title>. <source>Lancet Respir. Med.</source> <volume>8</volume> (<issue>3</issue>), <fpage>277</fpage>&#x2013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(19)30354-6</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Woersching</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Spyropoulos</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Piovella</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mahan</surname>
<given-names>C. E.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>European Union-28: an annualised cost-of-illness model for venous thromboembolism</article-title>. <source>Thromb. Haemost.</source> <volume>115</volume> (<issue>4</issue>), <fpage>800</fpage>&#x2013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1160/TH15-08-0670</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowden</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression</article-title>. <source>Int. J. Epidemiol.</source> <volume>44</volume> (<issue>2</issue>), <fpage>512</fpage>&#x2013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyv080</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowden</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Haycock</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator</article-title>. <source>Genet. Epidemiol.</source> <volume>40</volume> (<issue>4</issue>), <fpage>304</fpage>&#x2013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1002/gepi.21965</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brion</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Shakhbazov</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Calculating statistical power in Mendelian randomization studies</article-title>. <source>Int. J. Epidemiol.</source> <volume>42</volume> (<issue>5</issue>), <fpage>1497</fpage>&#x2013;<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyt179</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burgess</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Butterworth</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>S. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mendelian randomization analysis with multiple genetic variants using summarized data</article-title>. <source>Genet. Epidemiol.</source> <volume>37</volume> (<issue>7</issue>), <fpage>658</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1002/gepi.21758</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehn</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Beblo</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Depressed, biased, forgetful: the interaction of emotional and cognitive dysfunctions in depression</article-title>. <source>Neuropsychiatr</source> <volume>33</volume> (<issue>3</issue>), <fpage>123</fpage>&#x2013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1007/s40211-019-0307-4</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Wit</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Have</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Cuijpers</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>De Graaf</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Body mass index and risk for onset of mood and anxiety disorders in the general population: results from The Netherlands mental health survey and incidence study-2 (NEMESIS-2)</article-title>. <source>BMC Psychiatry</source> <volume>22</volume> (<issue>1</issue>), <fpage>522</fpage>. <pub-id pub-id-type="doi">10.1186/s12888-022-04077-w</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emdin</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Khera</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Kathiresan</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mendelian randomization</article-title>. <source>Jama</source> <volume>318</volume> (<issue>19</issue>), <fpage>1925</fpage>&#x2013;<lpage>1926</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2017.17219</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghanima</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wik</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Tavoly</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Enden</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jelsness-J&#xf8;rgensen</surname>
<given-names>L.-P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Late consequences of venous thromboembolism: measuring quality of life after deep vein thrombosis and pulmonary embolism</article-title>. <source>Thrombosis Res.</source> <volume>164</volume>, <fpage>170</fpage>&#x2013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.thromres.2017.07.025</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gold</surname>
<given-names>P. W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The organization of the stress system and its dysregulation in depressive illness</article-title>. <source>Mol. Psychiatry</source> <volume>20</volume> (<issue>1</issue>), <fpage>32</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.163</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartwig</surname>
<given-names>F. P.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bowden</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption</article-title>. <source>Int. J. Epidemiol.</source> <volume>46</volume> (<issue>6</issue>), <fpage>1985</fpage>&#x2013;<lpage>1998</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyx102</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tilling</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Orienting the causal relationship between imprecisely measured traits using GWAS summary data</article-title>. <source>PLoS Genet.</source> <volume>13</volume> (<issue>11</issue>), <fpage>e1007081</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1007081</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howard</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Hafferty</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shirali</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions</article-title>. <source>Nat. Neurosci.</source> <volume>22</volume> (<issue>3</issue>), <fpage>343</fpage>&#x2013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0326-7</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2023a</year>). <article-title>Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population</article-title>. <source>Osteoporos. Int.</source> <volume>34</volume>, <fpage>1719</fpage>&#x2013;<lpage>1727</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-023-06807-6</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2023b</year>). <article-title>Causal associations between polyunsaturated fatty acids and kidney function: a bidirectional Mendelian randomization study</article-title>. <source>Am. J. Clin. Nutr.</source> <volume>117</volume> (<issue>1</issue>), <fpage>199</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajcnut.2022.11.010</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dexpert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sauvant</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aouizerate</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Beau</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Relationship between body mass index and neuropsychiatric symptoms: evidence and inflammatory correlates</article-title>. <source>Brain Behav. Immun.</source> <volume>94</volume>, <fpage>104</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2021.02.031</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Noble</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rance</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>P. D.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Post-thrombotic panic syndrome": a thematic analysis of the experience of venous thromboembolism</article-title>. <source>Br. J. Health Psychol.</source> <volume>22</volume> (<issue>1</issue>), <fpage>8</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1111/bjhp.12213</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xf8;rgensen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Horv&#xe1;th-Puh&#xf3;</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Laugesen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Br&#xe6;kkan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>S&#xf8;rensen</surname>
<given-names>H. T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: a population-based cohort study</article-title>. <source>PLoS Med.</source> <volume>18</volume> (<issue>8</issue>), <fpage>e1003770</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1003770</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xf8;rgensen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Horv&#xe1;th-Puh&#xf3;</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Laugesen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Br&#xe6;kkan</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>S&#xf8;rensen</surname>
<given-names>H. T.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Venous thromboembolism and risk of depression: a population-based cohort study</article-title>. <source>J. Thromb. Haemost.</source> <volume>21</volume> (<issue>4</issue>), <fpage>953</fpage>&#x2013;<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtha.2022.12.006</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamat</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Blackshaw</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Surendran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Danesh</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations</article-title>. <source>Bioinformatics</source> <volume>35</volume> (<issue>22</issue>), <fpage>4851</fpage>&#x2013;<lpage>4853</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz469</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tritschler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Rodger</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Venous thromboembolism</article-title>. <source>Lancet</source> <volume>398</volume> (<issue>10294</issue>), <fpage>64</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)32658-1</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kowal</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Peyre</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Amad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pelissolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sch&#xfc;rhoff</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Psychotic, mood, and anxiety disorders and venous thromboembolism: a systematic review and meta-analysis</article-title>. <source>Psychosom. Med.</source> <volume>82</volume> (<issue>9</issue>), <fpage>838</fpage>&#x2013;<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1097/PSY.0000000000000863</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunutsor</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Seidu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khunti</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence</article-title>. <source>Ann. Med.</source> <volume>50</volume> (<issue>6</issue>), <fpage>529</fpage>&#x2013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1080/07853890.2018.1500703</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawlor</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Harbord</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Sterne</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Timpson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Davey Smith</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Mendelian randomization: using genes as instruments for making causal inferences in epidemiology</article-title>. <source>Stat. Med.</source> <volume>27</volume> (<issue>8</issue>), <fpage>1133</fpage>&#x2013;<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1002/sim.3034</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Depression and risk of venous thromboembolism: a population-based retrospective cohort study</article-title>. <source>Psychosom. Med.</source> <volume>77</volume> (<issue>5</issue>), <fpage>591</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1097/PSY.0000000000000193</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Balkwill</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sweetland</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reeves</surname>
<given-names>G. K.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Beral</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Antidepressants, depression, and venous thromboembolism risk: large prospective study of UK women</article-title>. <source>J. Am. Heart Assoc.</source> <volume>6</volume> (<issue>5</issue>), <fpage>e005316</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.116.005316</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pastori</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cormaci</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Marucci</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Franchino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Del Sole</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Capozza</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume> (<issue>4</issue>), <fpage>3169</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24043169</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piazza</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Beyond Virchow&#x27;s Triad: does cardiovascular inflammation explain the recurrent nature of venous thromboembolism?</article-title> <source>Vasc. Med.</source> <volume>20</volume> (<issue>2</issue>), <fpage>102</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1177/1358863X14568706</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmani</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haghighian Roudsari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bawadi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Khalooei Fard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: a systematic review and dose-response meta-analysis of cohort studies among four million participants</article-title>. <source>Thromb. Res.</source> <volume>192</volume>, <fpage>64</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.thromres.2020.05.014</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reitsma</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Rosendaal</surname>
<given-names>F. R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study</article-title>. <source>J. Thromb. Haemost.</source> <volume>2</volume> (<issue>4</issue>), <fpage>619</fpage>&#x2013;<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1111/j.1538-7836.2004.00689.x</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosendaal</surname>
<given-names>F. R.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Venous thrombosis: a multicausal disease</article-title>. <source>Lancet</source> <volume>353</volume> (<issue>9159</issue>), <fpage>1167</fpage>&#x2013;<lpage>1173</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(98)10266-0</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandrini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ieraci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Amadio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zar&#xe0;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barbieri</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Impact of acute and chronic stress on thrombosis in healthy individuals and cardiovascular disease patients</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>21</issue>), <fpage>7818</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21217818</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekula</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Del Greco</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Pattaro</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>K&#xf6;ttgen</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mendelian randomization as an approach to assess causality using observational data</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>27</volume> (<issue>11</issue>), <fpage>3253</fpage>&#x2013;<lpage>3265</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2016010098</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Aken</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Reitsma</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Rosendaal</surname>
<given-names>F. R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis</article-title>. <source>Br. J. Haematol.</source> <volume>116</volume> (<issue>1</issue>), <fpage>173</fpage>&#x2013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2141.2002.03245.x</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbanck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title>. <source>Nat. Genet.</source> <volume>50</volume> (<issue>5</issue>), <fpage>693</fpage>&#x2013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0099-7</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wendelboe</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Raskob</surname>
<given-names>G. E.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Global burden of thrombosis: epidemiologic aspects</article-title>. <source>Circ. Res.</source> <volume>118</volume> (<issue>9</issue>), <fpage>1340</fpage>&#x2013;<lpage>1347</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.306841</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wickersham</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sugg</surname>
<given-names>H. V. R.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Systematic review and meta-analysis: the association between child and adolescent depression and later educational attainment</article-title>. <source>J. Am. Acad. Child. Adolesc. Psychiatry</source> <volume>60</volume> (<issue>1</issue>), <fpage>105</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2020.10.008</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis</article-title>. <source>Clin. Rheumatol.</source> <volume>41</volume> (<issue>5</issue>), <fpage>1305</fpage>&#x2013;<lpage>1312</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-022-06052-y</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zi-Xin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yong-Gui</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Effect of antidepressants on venous thrombosis in patients with depression</article-title>. <source>J. Clin. Neurology</source> <volume>34</volume> (<issue>04</issue>), <fpage>300</fpage>&#x2013;<lpage>303</lpage>.</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Z&#xf6;ller</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sundquist</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sundquist</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: a nationwide epidemiological study</article-title>. <source>Thromb. Res.</source> <volume>129</volume> (<issue>5</issue>), <fpage>577</fpage>&#x2013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1016/j.thromres.2011.07.050</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>